Androgen-insensitive prostatic cancer

Clinical trials for Androgen-insensitive prostatic cancer explained in plain language.

Never miss a new study

Get alerted when new Androgen-insensitive prostatic cancer trials appear

Sign up with your email to follow new studies for Androgen-insensitive prostatic cancer, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Terminated 1

Experimental drug targets Hard-to-Treat cancers, but trial ends early

Disease control Stopped early

This study tested an experimental drug called vobramitamab duocarmazine in people with advanced prostate cancer and other solid tumors that stopped responding to standard treatments. The goal was to see if the drug could shrink tumors or slow cancer growth. The trial was terminat…

Matched conditions: ANDROGEN-INSENSITIVE PROSTATIC CANCER

Phase 2 • Sponsor: MacroGenics • Aim: Disease control

Last updated Jun 27, 2026 09:04 UTC

Androgen-insensitive prostatic cancer

Get alerted when new Androgen-insensitive prostatic cancer trials appear

Experimental drug targets Hard-to-Treat cancers, but trial ends early